Marty Bonick, president and CEO of Brentwood-based Ardent Health, saw his total compensation decline by roughly $850,000 in 2025 to about $6.1 million, according to a proxy statement filed with the Securities and Exchange Commission.
Ardent went public in July 2024. Here are the system’s six highest-earning executives in 2025:
1. Marty Bonick, president and CEO
- Salary: $1,076,000
- Stock awards: $5,000,004
- Other compensation: $14,000
- Total 2025 compensation: $6,090,004
- Total 2024 compensation: $6,939,257
2. Alfred Lumsdaine, CFO
- Salary: $650,235
- Bonus: $50,000
- Stock awards: $2,000,010
- Other compensation: $14,000
- Total 2025 compensation: $2,714,245
- Total 2024 compensation: $3,427,914
3. David Caspers, COO
- Salary: $511,541
- Bonus: $551,386
- Stock awards: $1,325,021
- Other compensation: $59,622
- Total 2025 compensation: $2,447,570
- Total 2024 compensation: N/A
- Total 2024 compensation: N/A
4. David Schultz, former president of hospital operations
- Salary: $389,866
- Stock awards: $1,000,012
- Other compensation: $674,241
- Total 2025 compensation: $2,064,119
- Total 2024 compensation: $3,015,858
5. Ethan Chernin, former president of health services
- Salary: $612,466
- Bonus: $23,175
- Stock awards: $775,001
- Other compensation: $73,672
- Total 2025 compensation: $1,484,314
- Total 2024 compensation: $1,492,519
6. Stephen Petrovich, executive vice president and general counsel
- Salary: $547,051
- Bonus: $35,190
- Stock awards: $825,010
- Other compensation: $14,000
- Total 2025 compensation: $1,421,251
- Total 2024 compensation: $2,037,623
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
